Clinical Trials · NCT02065323
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Oscar Goodman, Jr.
- Enrollment
- 0
- Start date
- Not specified
- Locations
- 1 site, United States
- Primary endpoint
- Time to onset of castration resistant prostate cancer (CRPC)